Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
94.81 USD | +2.39% | +0.46% | +10.91% |
09/05 | Haemonetics' Fiscal Q4 Adjusted Earnings, Revenue Rise | MT |
09/05 | Haemonetics Corporation Reports Earnings Results for the Full Year Ended March 30, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.91% | 4.7B | |
-4.57% | 182B | |
+0.24% | 110B | |
-3.90% | 67.92B | |
+3.16% | 50.96B | |
+9.66% | 44.7B | |
+2.70% | 40.66B | |
+21.56% | 27.6B | |
+4.31% | 26.63B | |
-0.12% | 24.98B |
- Stock Market
- Equities
- HAE Stock
- News Haemonetics Corporation
- Barrington Ups Price Target on Haemonetics to $111 From $103, Keeps Outperform Rating